41 Stocks Moving In Friday's Mid-Day Session



  • IVERIC bio, Inc. ISEE shares climbed 64.4% to $14.29 after Apellis Pharmaceuticals reported results from its Phase 3 DERBY and OAKS studies in geographic atrophy. IVERIC Bio, a competitor to Apellis, is also working on a product to treat geographic atrophy, called Zimura. Stifel initiated coverage on IVERIC bio with a Buy rating and announced a price target of $22.
  • Echo Global Logistics, Inc. ECHO surged 53.8% to $48.16 after the company agreed to be acquired by private equity firm The Jordan Company.
  • Endo International plc ENDP shares climbed 53% to $3.21 after the company said it has settled three consolidated opioid cases pending in Suffolk County Supreme Court in the State of New York. As a result of the settlement, Endo has been severed from the trial.
  • PaySign, Inc. PAYS jumped 24.5% to $3.6615. PaySign shares climbed around 25% on Thursday following circulation of an earlier TipRanks article titled '3 "Strong Buy" Stocks Flirting With a Bottom' mentioning the stock.
  • Camber Energy, Inc. CEI shares surged 23.8% to $1.6091 after jumping 31% on Thursday.
  • Aterian, Inc. ATER gained 23.8% to $12.63.
  • Elite Education Group International Limited EEIQ surged 22.7% to $6.41 after jumping 20% on Thursday.
  • Affirm Holdings, Inc. AFRM rose 22% to $112.38 after the company reported better-than-expected Q4 sales and issued strong Q1 sales guidance.
  • T2 Biosystems, Inc. TTOO rose 19.4% to $1.0350 after the company announced its T2SARS-CoV-2 panel proved capable of detecting the Mu B.1.621 and Iota B.1.526 variants of the SARS-CoV-2 virus.
  • Vince Holding Corp. VNCE rose 18.2% to $7.93 after the company reported better-than-expected Q2 results.
  • NGM Biopharmaceuticals, Inc. NGM gained 16.7% to $24.80.
  • Sonim Technologies, Inc. SONM shares rose 16.3% to $0.6859 after gaining over 21% on Thursday.
  • Arbutus Biopharma Corporation ABUS jumped 15.9% to $4.4850 after gaining over 15% on Thursday.
  • UP Fintech Holding Limited TIGR rose 14.8% to $15.37 after reporting Q2 results.
  • Cedar Realty Trust, Inc. CDR gained 14.1% to $19.40 after the company reported dual-track review of strategic alternatives. The company also named Jennifer Bitterman Chief Financial Officer.
  • Greenlane Holdings, Inc. GNLN jumped 13.5% to $2.8950.
  • SOS Limited SOS gained 12.4% to $2.9001 after the company reported that revenue in the first half of 2021 totaled $184.5 million, representing an increase of 17 times year over year.
  • The Dixie Group, Inc. DXYN jumped 12% to $4.9850.
  • IronNet, Inc. IRNT gained 11.5% to $19.30.
  • Farmmi, Inc. FAMI climbed 11.3% to $0.4760. Farmmi’s subsidiary Zhejiang Forest Food Co Ltd recently won a new product order for its dried whole Shiitake mushrooms.
  • CareMax, Inc. CMAX gained 10.7% to $9.39. Cowen & Co. initiated coverage on CareMax with an Outperform rating and announced a price target of $14.
  • National Beverage Corp. FIZZ climbed 9.2% to $51.12 after the company reported Q1 EPS and sales results were higher year over year.
  • Katapult Holdings, Inc. KPLT rose 7.8% to $6.79. KeyBanc recently said Katapult is 'well-positioned' to benefit from potential new partnerships and cited 'potential AMZN opportunities.'
  • Dave & Buster's Entertainment, Inc. PLAY rose 7.2% to $38.00 after the company reported better-than-expected Q2 results.

Check out these big penny stock gainers and losers


  • Apellis Pharmaceuticals, Inc. APLS shares fell 48.7% to $28.56 after the company reported mixed top-line results from the Phase 3 DERBY and OAKS studies evaluating intravitreal pegcetacoplan in 1,258 adults with geographic atrophy secondary to age-related macular degeneration. The OAKS study met the primary endpoint for both monthly and every-other-month treatment with pegcetacoplan, demonstrating a significant reduction in GA lesion growth of 22% and 16%, respectively, compared to pooled sham at 12 months. However the DERBY study did not meet the primary endpoint of GA lesion growth, showing a reduction of 12% and 11%, with monthly and every-other-month treatment, respectively, compared to pooled sham at 12 months.
  • Kaival Brands Innovations Group, Inc. KAVL tumbled 45.4% to $5.58 after climbing over 20% on Thursday.
  • Mersana Therapeutics, Inc. MRSN fell 35.2% to $9.12.
  • Impel NeuroPharma, Inc. IMPL shares dropped 20.2% to $16.85 after the company reported pricing of $45.0 million public offering.
  • Lakeland Industries, Inc. LAKE dipped 15.5% to $20.20 after reporting downbeat Q2 sales.
  • TMC the metals company Inc. TMC dropped 15.1% to $9.25.
  • Tuesday Morning Corporation TUEM dropped 14.5% to $1.9999. Tuesday Morning shares fell 45% on Thursday after the company reported downbeat Q4 earnings.
  • Clarus Therapeutics Holdings Inc. CRXT dipped 12.8% to $8.39.
  • Hippo Holdings Inc. HIPO fell 12.5% to $6.00. The company earlier reported a Gross Loss Ratio of 161% for the three months ended June 30.
  • RLX Technology Inc. RLX fell 12.1% to $6.06.
  • RxSight, Inc. RXST dropped 11.3% to $14.19.
  • Sumo Logic, Inc. SUMO shares fell 11.3% to $17.85 after the company reported Q2 earnings results and issued Q3 guidance. Piper Sandler downgraded Sumo Logic from Overweight to Neutral and lowered the price target from $24 to $20.
  • PharmaCyte Biotech, Inc. PMCB dropped 10.6% to $3.5292.
  • Maravai LifeSciences Holdings, Inc. MRVI shares fell 10.1% to $47.95 after the company announced a 20 million share offering of Class A common stock by selling shareholders to be priced at $50 per share..
  • Teradata Corporation TDC dipped 9.5% to $50.99. Several analysts raised their price targets on the stock.
  • Traeger, Inc. COOK fell 9.1% to $23.24 after the company reported Q2 earnings results.
  • The Kroger Co. KR dropped 8.6% to $42.14 despite reporting upbeat quarterly results.
Market News and Data brought to you by Benzinga APIs
Posted In: NewsPenny StocksSmall CapIntraday UpdateMarketsMoversTrading IdeasMid-Day MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!